COVID-19 Test Maker Hit with Investor’s Class Action Over ‘100% Accurate’ Claim
June 16, 2020 A class action alleges Co-Diagnostics, Inc. caused investors to lose millions when the FDA contradicted the company’s “100% accuracy” claims for its COVID-19 tests.